Author:
Partownavid Parisa,Romito Bryan T.,Ching Willy,Berry Ashley A.,Barkulis Charles T.,Nguyen KimNgan P.,Jahr Jonathan S.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference24 articles.
1. . A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.;Bom;Angew Chem Int Ed Engl,2002
2. . First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.;Gijsenbergh;Anesthesiology,2005
3. . Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.;Sorgenfrei;Anesthesiology,2006
4. . Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.;Suy;Anesthesiology,2007
5. . A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block.;Groudine;Anesth Analg,2007
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献